AI
VCYT icon

Axiom Investors’s Veracyte VCYT Stock Holding History

Axiom Investors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,465
Closed -$2.23M – 136
2021
Q1 		$2.23M Sell
41,465
-8,015
-16% -$462K 0.04% 119
2020
Q4 		$2.42M Buy
+49,480
New +$2.29M 0.04% 110
2017
Q4 		– Sell
-388,328
Closed -$3.41M – 156
2017
Q3 		$3.41M Buy
388,328
+140,783
+57% +$1.14M 0.08% 102
2017
Q2 		$2.06M Buy
247,545
+9,747
+4% +$79.5K 0.05% 121
2017
Q1 		$2.18M Sell
237,798
-49,339
-17% -$404K 0.06% 116
2016
Q4 		$2.22M Buy
+287,137
New +$2.15M 0.06% 123

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axiom Investors's VCYT Position: Q2 2021 in Review

Axiom Investors sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 41,465 shares — an estimated $2.23M sold.

Axiom Investors first reported a position in VCYT in Q4 2016 and held it in 6 quarters. The position peaked at $3.41M in Q3 2017. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Axiom Investors reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Axiom Investors sold 41,465 Veracyte shares in Q2 2021, an estimated $2.23M.
  • Axiom Investors first reported a position in Veracyte in Q4 2016 and held it in 6 quarters.
  • Axiom Investors's Veracyte position peaked at $3.41M in Q3 2017.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Axiom Investors's 13F filing for Q2 2021, filed 13 Aug 2021.